Is the Aberrant Expression of p53 by Immunocytochemistry a Surrogate Marker of TP53 Mutation and/or Deletion in Chronic Lymphocytic Leukemia?

被引：4

作者：

Marinelli, Marilisa ^{[1
]}

Raponi, Sara ^{[1
]}

Del Giudice, Ilaria ^{[1
]}

De Propris, Maria Stefania ^{[1
]}

Nanni, Mauro ^{[1
]}

Intoppa, Stefania ^{[1
]}

Milani, Maria Laura ^{[1
]}

Mauro, Francesca Romana ^{[1
]}

Guarini, Anna ^{[1
]}

Foa, Robin ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, Rome, Italy

来源：

AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2011年 / 135卷 / 01期

关键词：

SURVIVAL; GENE; MALIGNANCIES; CANCER;

D O I：

10.1309/AJCPFMV43IFPRTWK

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：173 / 174

页数：2

共 14 条

[1]

[Anonymous], N ENGL J MED

[2] Aberrant Nuclear p53 Expression Predicts Hemizygous 17p (TP53) Deletion in Chronic Lymphocytic Leukemia [J].

Chang, Hong ;

Jiang, Allan M. ;

Qi, Connie X. Y. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) :70-74

[3] p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis [J].

Cordone, I ;

Masi, S ;

Mauro, FR ;

Soddu, S ;

Morsilli, O ;

Valentini, T ;

Vegna, ML ;

Guglielmi, C ;

Mancini, F ;

Giuliacci, S ;

Sacchi, A ;

Mandelli, F ;

Foa, R .

BLOOD, 1998, 91 (11) :4342-4349

[4] P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS [J].

DOHNER, H ;

FISCHER, K ;

BENTZ, M ;

HANSEN, K ;

BENNER, A ;

CABOT, G ;

DIEHL, D ;

SCHLENK, R ;

COY, J ;

STILGENBAUER, S ;

VOLKMANN, M ;

GALLE, PR ;

POUSTKA, A ;

HUNSTEIN, W ;

LICHTER, P .

BLOOD, 1995, 85 (06) :1580-1589

[5] Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus [J].

Dreger, P. ;

Corradini, P. ;

Kimby, E. ;

Michallet, M. ;

Milligan, D. ;

Schetelig, J. ;

Wiktor-Jedrzejczak, W. ;

Niederwieser, D. ;

Hallek, M. ;

Montserrat, E. .

LEUKEMIA, 2007, 21 (01) :12-17

[6] P53 MUTATIONS IN HUMAN LYMPHOID MALIGNANCIES - ASSOCIATION WITH BURKITT-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA [J].

GAIDANO, G ;

BALLERINI, P ;

GONG, JZ ;

INGHIRAMI, G ;

NERI, A ;

NEWCOMB, EW ;

MAGRATH, IT ;

KNOWLES, DM ;

DALLAFAVERA, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5413-5417

[7]

GREENBLATT MS, 1994, CANCER RES, V54, P4855

[8] Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features [J].

Guarini, A ;

Gaidano, G ;

Mauro, FR ;

Capello, D ;

Mancini, F ;

De Propris, MS ;

Mancini, M ;

Orsini, E ;

Gentile, M ;

Breccia, M ;

Cuneo, A ;

Castoldi, G ;

Foa, R .

BLOOD, 2003, 102 (03) :1035-1041

[9] VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia [J].

Kröber, A ;

Seiler, T ;

Benner, A ;

Bullinger, L ;

Brückle, E ;

Lichter, P ;

Döhner, H ;

Stilgenbauer, S .

BLOOD, 2002, 100 (04) :1410-1416

[10]

LEPELLEY P, 1994, LEUKEMIA, V8, P1342

← 1 2 →